105 related articles for article (PubMed ID: 35798468)
1. Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study.
Osterlund P; Kinos S; Pfeiffer P; Salminen T; Kwakman JJM; Frödin JE; Shah CH; Sorbye H; Ristamäki R; Halonen P; Soveri LM; Heervä E; Ålgars A; Bärlund M; Hagman H; McDermott R; O'Reilly M; Röckert R; Liposits G; Kallio R; Flygare P; Teske AJ; van Werkhoven E; Punt CJA; Glimelius B
ESMO Open; 2022 Jun; 7(3):100427. PubMed ID: 35798468
[TBL] [Abstract][Full Text] [Related]
2. Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study).
Kinos S; Hagman H; Halonen P; Soveri LM; O'Reilly M; Pfeiffer P; Frödin JE; Sorbye H; Heervä E; Liposits G; Kallio R; Ålgars A; Ristamäki R; Salminen T; Bärlund M; Shah CH; McDermott R; Röckert R; Flygare P; Kwakman J; Teske A; Punt C; Glimelius B; Österlund P
Acta Oncol; 2024 May; 63():248-258. PubMed ID: 38698698
[TBL] [Abstract][Full Text] [Related]
3. Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity.
Ma WW; Saif MW; El-Rayes BF; Fakih MG; Cartwright TH; Posey JA; King TR; von Borstel RW; Bamat MK
Cancer; 2017 Jan; 123(2):345-356. PubMed ID: 27622829
[TBL] [Abstract][Full Text] [Related]
4. Alternative Treatment Options in Patients with Colorectal Cancer Who Encounter Fluoropyrimidine-Induced Cardiotoxicity.
Saif MW
Onco Targets Ther; 2020; 13():10197-10206. PubMed ID: 33116601
[TBL] [Abstract][Full Text] [Related]
5. Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge.
Vater LB; Lefebvre B; Turk A; Clasen SC
Curr Oncol Rep; 2022 Jul; 24(7):943-950. PubMed ID: 35347593
[TBL] [Abstract][Full Text] [Related]
6. Fluoropyrimidine-induced cardiac toxicity: challenging the current paradigm.
Clasen SC; Ky B; O'Quinn R; Giantonio B; Teitelbaum U; Carver JR
J Gastrointest Oncol; 2017 Dec; 8(6):970-979. PubMed ID: 29299356
[TBL] [Abstract][Full Text] [Related]
7. A novel outpatient regimen in management of fluoropyrimidine-induced cardiotoxicity.
Kasi A; Gaudel P; Lekkala M; Al-Rajabi R; Saeed A; Sun W; Porter C
J Oncol Pharm Pract; 2023 Dec; 29(8):1951-1956. PubMed ID: 36883259
[TBL] [Abstract][Full Text] [Related]
8. Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm?
Chong J; Ho AF; Yap J; Bulluck H; Hausenloy DJ
Cond Med; 2019 Oct; 2(5):204-212. PubMed ID: 32133437
[TBL] [Abstract][Full Text] [Related]
9. Myocardial Ischemia Induced by 5-Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study.
Dyhl-Polk A; Schou M; Vistisen KK; Sillesen AS; Serup-Hansen E; Faber J; Klausen TW; Bojesen SE; Vaage-Nilsen M; Nielsen DL
Oncologist; 2021 Mar; 26(3):e403-e413. PubMed ID: 32959474
[TBL] [Abstract][Full Text] [Related]
10. S-1 as an alternative treatment after 5-fluorouracil-induced coronary vasospasm in a patient with small bowel adenocarcinoma: a case report.
Mitome N; Machida N; Shichiri Y; Kuwashima H; Murai A; Maeda S
Int Cancer Conf J; 2024 Jan; 13(1):40-44. PubMed ID: 38187174
[TBL] [Abstract][Full Text] [Related]
11. Assessing the Hepatotoxic Effects of Fluoropyrimidine Chemotherapy in Male Iraqi Colorectal Cancer Patients.
Challoob MA; Mohammed NS
Cureus; 2024 Apr; 16(4):e58126. PubMed ID: 38741871
[TBL] [Abstract][Full Text] [Related]
12. Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients.
Cura Y; Sánchez-Martín A; Márquez-Pete N; González-Flores E; Martínez-Martínez F; Pérez-Ramírez C; Jiménez-Morales A
Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004528
[TBL] [Abstract][Full Text] [Related]
13. Two patients with fluoropyrimidine overdose successfully managed without uridine triacetate.
Kats CJ; Jochems A; Jeurissen FJ; Ledeboer A; van den Berg RB
J Oncol Pharm Pract; 2023 Dec; 29(8):2037-2040. PubMed ID: 37499216
[TBL] [Abstract][Full Text] [Related]
14. 5-fluorouracil therapeutic drug monitoring and adverse events in a Romanian population.
Deac AL; Pop RM; Burz CC; Bocşan IC; Militaru C; Suciu Ş; Buzoianu AD
Med Pharm Rep; 2023 Oct; 96(4):413-419. PubMed ID: 37970190
[TBL] [Abstract][Full Text] [Related]
15. Gene expression responses reflecting 5-FU-induced toxicity: Comparison between patient colon tissue and 3D human colon organoids.
Rodrigues D; van Kampen R; van Bodegraven AA; Kleinjans JCS; Jennen DGJ; de Kok TM
Toxicol Lett; 2022 Dec; 371():17-24. PubMed ID: 36183961
[TBL] [Abstract][Full Text] [Related]
16. DPYD testing makes fluoropyrimidine chemotherapy safer.
Traynor K
Am J Health Syst Pharm; 2024 Apr; 81(9):e197-e198. PubMed ID: 38491984
[No Abstract] [Full Text] [Related]
17. Response to letter entitled: Re: Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France.
Hill C
Eur J Cancer; 2023 Aug; 189():112929. PubMed ID: 37327685
[No Abstract] [Full Text] [Related]
18. Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer.
Punt CJA; Heinemann V; Maughan T; Cremolini C; Van Cutsem E; McDermott R; Bodoky G; André T; Osterlund P; Teske AJ; Pfeiffer P
ESMO Open; 2023 Apr; 8(2):101199. PubMed ID: 37018874
[TBL] [Abstract][Full Text] [Related]
19. ST-Segment Elevation Myocardial Infarction Caused by 5-Fluorouracil-Related Cardiotoxicity.
Balaji N; Dixit P; Adams AM; Faiz F; Ngwainmbi D; Henry G; Ghasemzadeh N
Cureus; 2024 Jan; 16(1):e52864. PubMed ID: 38406077
[TBL] [Abstract][Full Text] [Related]
20. Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand?
van Nassau SCMW; Bol GM; van der Baan FH; Roodhart JML; Vink GR; Punt CJA; May AM; Koopman M; Derksen JWG
Curr Treat Options Oncol; 2024 Apr; 25(4):405-426. PubMed ID: 38367182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
